A comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, EMA and FDA
Consensus of regulatory decisions on the same Marketing Authorization Application (MAA) are critical for stakeholders. In this context, regulatory decision patterns from the Swissmedic (SMC), the US Food and [...]